309.33
price down icon1.02%   -3.18
after-market Dopo l'orario di chiusura: 309.33
loading

Beone Medicines Ltd Adr Borsa (ONC) Ultime notizie

pulisher
06:08 AM

Insider Selling: BeOne Medicines (NASDAQ:ONC) SVP Sells 11,013 Shares of Stock - MarketBeat

06:08 AM
pulisher
04:28 AM

BeOne Medicines (NASDAQ:ONC) COO Xiaobin Wu Sells 39,936 Shares - MarketBeat

04:28 AM
pulisher
12:34 PM

Insider Selling: BeOne Medicines (NASDAQ:ONC) COO Sells 49,858 Shares of Stock - MarketBeat

12:34 PM
pulisher
Aug 19, 2025

BeOne Medicines (NASDAQ:ONC) Sets New 52-Week HighShould You Buy? - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.

Aug 19, 2025
pulisher
Aug 17, 2025

BeOne Medicines (NASDAQ:ONC) Hits New 1-Year High – What’s Next? - Defense World

Aug 17, 2025
pulisher
Aug 12, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap DownShould You Sell? - MarketBeat

Aug 12, 2025
pulisher
Aug 10, 2025

BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) CFO Aaron Rosenberg Sells 1,190 Shares - MarketBeat

Aug 10, 2025
pulisher
Aug 08, 2025

BeOne Medicines (NASDAQ:ONC) Sets New 12-Month HighWhat's Next? - MarketBeat

Aug 08, 2025
pulisher
Aug 06, 2025

BeOne Medicines DRC earnings missed by $0.04, revenue topped estimates - Investing.com India

Aug 06, 2025
pulisher
Aug 05, 2025

Analysts Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) PT at $327.56 - Defense World

Aug 05, 2025
pulisher
Aug 04, 2025

Chan Henry Lee Sells 920 Shares of BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Stock - MarketBeat

Aug 04, 2025
pulisher
Aug 04, 2025

Insider Selling: BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Insider Sells 259 Shares of Stock - MarketBeat

Aug 04, 2025
pulisher
Aug 03, 2025

BeOne Medicines (NASDAQ:ONC) Reaches New 12-Month HighHere's What Happened - MarketBeat

Aug 03, 2025
pulisher
Jul 29, 2025

BeOne Medicines stock hits 52-week high at 304.0 USD - Investing.com India

Jul 29, 2025
pulisher
Jul 29, 2025

Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End - Ariva

Jul 29, 2025
pulisher
Jul 28, 2025

BeOne Medicines stock rises after positive EU opinion for lung cancer drug - Investing.com India

Jul 28, 2025
pulisher
Jul 27, 2025

Lai Wang Sells 700 Shares of BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Stock - MarketBeat

Jul 27, 2025
pulisher
Jul 25, 2025

Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Jul 25, 2025
pulisher
Jul 20, 2025

BeOne Medicines (NASDAQ:ONC) Reaches New 12-Month High After Analyst Upgrade - MarketBeat

Jul 20, 2025
pulisher
Jul 18, 2025

BeOne Medicines (NASDAQ:ONC) Reaches New 52-Week High Following Analyst Upgrade - Defense World

Jul 18, 2025
pulisher
Jul 15, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap UpTime to Buy? - MarketBeat

Jul 15, 2025
pulisher
Jul 14, 2025

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) CEO Sells $7,044,470.76 in Stock - Defense World

Jul 14, 2025
pulisher
Jul 08, 2025

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jul 08, 2025
pulisher
Jul 08, 2025

AFC Gamma (NASDAQ:AFCG) Shares Down 4.9% – What’s Next? - Defense World

Jul 08, 2025
pulisher
Jun 29, 2025

BeOne Medicines (NASDAQ:ONC) Stock Price Down 3.6% Following Insider Selling - MarketBeat

Jun 29, 2025
pulisher
Jun 28, 2025

BeOne Medicines (NASDAQ:ONC) Receives “Outperform” Rating from Royal Bank Of Canada - Defense World

Jun 28, 2025
pulisher
Jun 27, 2025

BeOne Medicines stock rating reiterated at Outperform by RBC Capital - Investing.com

Jun 27, 2025
$129.45
price up icon 1.76%
$660.97
price up icon 0.62%
$111.30
price down icon 0.09%
$25.87
price up icon 2.05%
$86.20
price up icon 0.87%
Capitalizzazione:     |  Volume (24 ore):